Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelfinavir with Radical Radiotherapy in NSCLC
NCT01447589Phase 2Withdrawn
- Sponsor
- Oxford University Hospitals
- Start
- Feb 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nelfinavir in non-small cell lung cancer (NSCLC), sponsored by Oxford University Hospitals. Planned start Feb 2012; status: withdrawn.
02
Drugs
nelfinavir
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01447589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01447589.